FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for Newly Diagnosed AML By Ogkologos - June 3, 2026 133 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study ASTX727-07 Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Toxin-Based Drug Moxetumomab Pasudotox May Be New Option for Rare Leukemia June 5, 2018 From Awareness to Action: Putting Cancer Disparities in the Rearview Mirror March 21, 2024 A Third Dose of BNT162b2 is Safe and Improves Humoural Immunity... October 12, 2021 Plans for NCI’s Fiscal Year 2019 Budget December 18, 2018 Load more HOT NEWS Two Early Studies Show Rapid Antitumour CAR-Mediated Responses, but Often of... German Shepherds Detect Fast-Growing Form Of Breast Cancer And Save Their... ΚΑΡΚΙΝΟΣ ΠΝΕΥΜΟΝΑ Colorectal Cancer Screening: Where Does the Shield Liquid Biopsy Fit In?
